Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avricore Health Inc. (AVCRF)
OTHER OTC:AVCRF
Holding AVCRF?
Track your performance easily
AVCRF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.04 - $0.25
Previous Close$0.04
Volume950.00
Average Volume (3M)81.41K
Market Cap
$4.35M
Enterprise Value$3.94M
Total Cash (Recent Filing)C$565.61K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.35
Next Earnings
Nov 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding99,869,664
10 Day Avg. Volume51,267
30 Day Avg. Volume81,412
Standard Deviation0.55
R-Squared0.02
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)2.13
Price to Sales (P/S)1.34
Price to Cash Flow (P/CF)135.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Avricore Health News
PremiumCompany Announcements
Avricore Health Shifts Focus to UK Market
PremiumCompany Announcements
Avricore Health Reports Soaring Mid-Year Profits
PremiumCompany Announcements
Avricore Health Grants Stock Options and Touts HealthTab™
PremiumCompany Announcements
Avricore Health Boasts Robust Mid-Year FinancialsPremiumCompany Announcements
Avricore Health Achieves First Net Profitability
PremiumCompany Announcements
Avricore Health Posts Q1 Profit and Asset Growth
PremiumCompany Announcements
Avricore Health Celebrates First Profitable QuarterPremiumCompany Announcements
Avricore Expands Health Testing in Rexall PharmaciesOwnership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AVCRF FAQ
What was Avricore Health Inc.’s price range in the past 12 months?
Avricore Health Inc. lowest stock price was $0.04 and its highest was $0.25 in the past 12 months.
What is Avricore Health Inc.’s market cap?
Currently, no data Available
When is Avricore Health Inc.’s upcoming earnings report date?
Avricore Health Inc.’s upcoming earnings report date is Nov 28, 2024 which is in 4 days.
How were Avricore Health Inc.’s earnings last quarter?
Avricore Health Inc. released its earnings results on Aug 29, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Avricore Health Inc. overvalued?
According to Wall Street analysts Avricore Health Inc.’s price is currently Overvalued.
Does Avricore Health Inc. pay dividends?
Avricore Health Inc. does not currently pay dividends.
What is Avricore Health Inc.’s EPS estimate?
Avricore Health Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avricore Health Inc. have?
Avricore Health Inc. has 101,289,665 shares outstanding.
What happened to Avricore Health Inc.’s price movement after its last earnings report?
Avricore Health Inc. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Avricore Health Inc.?
Currently, no hedge funds are holding shares in AVCRF
---
Avricore Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.34%
12-Months-Change
Fundamentals
Return on Equity
-0.29%
Trailing 12-Months
Asset Growth
18.11%
Trailing 12-Months
Company Description
Avricore Health Inc.
Avricore Health, Inc. engages in the manufacture and distribution of generic and over-the-counter (OTC) pharmaceutical products. It firm operates through the Products and Point of Care business division. The Products business division offers OTC pharmaceutical through its Corozon platform. The Point of Care business division provides point of care screening services through its HealthTab system and software platform. Its products include Hema-fer, Cortivera, and Sennace. The company was founded on May 30, 2000 and is headquartered in Vancouver, Canada.
---
Technical Analysis
---